Financials Nutrien Ltd.

Equities

NTR

CA67077M1086

Agricultural Chemicals

Market Closed - Toronto S.E. 16:00:00 2024-06-14 EDT 5-day change 1st Jan Change
70.32 CAD -0.16% Intraday chart for Nutrien Ltd. -7.76% -5.80%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27,400 27,364 42,922 37,922 27,847 25,304 - -
Enterprise Value (EV) 1 37,833 36,130 53,269 48,949 39,472 35,868 35,489 35,154
P/E ratio 28.1 x 59.4 x 13.6 x 5.14 x 22.3 x 13.3 x 13.7 x 16.2 x
Yield 3.68% 3.87% 2.45% 2.63% 3.76% 4.14% 4.27% 4.36%
Capitalization / Revenue 1.42 x 1.36 x 1.6 x 1.02 x 0.99 x 0.95 x 0.92 x 0.9 x
EV / Revenue 1.96 x 1.8 x 1.98 x 1.32 x 1.41 x 1.34 x 1.29 x 1.24 x
EV / EBITDA 9.4 x 9.85 x 7.48 x 4.02 x 6.52 x 6.43 x 6.27 x 6.2 x
EV / FCF 19.5 x 19 x 25.3 x 8.63 x 16.5 x 15 x 15.4 x 16.5 x
FCF Yield 5.12% 5.26% 3.95% 11.6% 6.07% 6.65% 6.49% 6.07%
Price to Book 1.2 x 1.22 x 1.77 x 1.43 x 1.11 x 1 x 0.98 x 0.96 x
Nbr of stocks (in thousands) 572,900 569,146 570,786 520,184 494,547 494,689 - -
Reference price 2 47.83 48.08 75.20 72.90 56.31 51.15 51.15 51.15
Announcement Date 20-02-18 21-02-17 22-02-16 23-02-15 24-02-21 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 19,255 20,053 26,861 37,012 28,082 26,777 27,466 28,271
EBITDA 1 4,025 3,667 7,126 12,170 6,058 5,582 5,664 5,669
EBIT 1 1,862 902 4,781 10,809 2,745 3,384 3,372 3,165
Operating Margin 9.67% 4.5% 17.8% 29.2% 9.77% 12.64% 12.28% 11.2%
Earnings before Tax (EBT) 1 1,308 382 4,168 10,246 1,952 2,485 2,381 2,208
Net income 1 992 459 3,153 7,660 1,258 1,929 1,957 1,634
Net margin 5.15% 2.29% 11.74% 20.7% 4.48% 7.2% 7.12% 5.78%
EPS 2 1.700 0.8100 5.520 14.18 2.530 3.848 3.738 3.157
Free Cash Flow 1 1,937 1,900 2,103 5,672 2,395 2,387 2,302 2,132
FCF margin 10.06% 9.47% 7.83% 15.32% 8.53% 8.91% 8.38% 7.54%
FCF Conversion (EBITDA) 48.12% 51.81% 29.51% 46.61% 39.53% 42.76% 40.64% 37.62%
FCF Conversion (Net income) 195.26% 413.94% 66.7% 74.05% 190.38% 123.73% 117.65% 130.55%
Dividend per Share 2 1.760 1.860 1.840 1.920 2.120 2.120 2.183 2.232
Announcement Date 20-02-18 21-02-17 22-02-16 23-02-15 24-02-21 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 7,069 7,454 14,285 7,984 7,289 5,908 11,402 5,368 5,404 5,151 10,699 5,418 5,354 5,203 10,618
EBITDA 1 2,463 2,615 4,993 2,467 2,095 1,421 2,478 1,084 1,075 1,055 2,214 1,160 1,199 963.2 2,279
EBIT 1 1,827 1,999 4,945 2,206 1,659 939 1,128 385 293 419 1,698 669.2 681 353 1,656
Operating Margin 25.85% 26.82% 34.62% 27.63% 22.76% 15.89% 9.89% 7.17% 5.42% 8.13% 15.87% 12.35% 12.72% 6.78% 15.59%
Earnings before Tax (EBT) 1 1,581 1,890 4,815 2,070 1,471 769 924 179 80 240 1,537 458.7 475.7 160.5 1,460
Net income 1 1,201 1,378 3,593 1,577 1,112 571 440 75 172 158 1,134 336.7 361.7 122 1,087
Net margin 16.99% 18.49% 25.15% 19.75% 15.26% 9.66% 3.86% 1.4% 3.18% 3.07% 10.6% 6.21% 6.76% 2.34% 10.24%
EPS 2 2.110 2.490 6.510 2.940 2.150 1.140 0.8900 0.1500 0.3500 0.3200 2.312 0.7125 0.7350 0.2500 2.265
Dividend per Share 2 0.4600 0.4800 0.4800 0.4600 0.5000 0.5300 0.5300 0.5300 0.5300 0.5400 0.5219 0.5219 0.5219 0.5247 0.5247
Announcement Date 22-02-16 22-05-02 22-08-03 22-11-02 23-02-15 23-05-10 23-08-02 23-11-01 24-02-21 24-05-08 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 10,433 8,766 10,347 11,027 11,625 10,563 10,185 9,850
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.592 x 2.391 x 1.452 x 0.9061 x 1.919 x 1.892 x 1.798 x 1.738 x
Free Cash Flow 1 1,937 1,900 2,103 5,672 2,395 2,387 2,302 2,133
ROE (net income / shareholders' equity) 5.36% 4.54% 13.7% 31% 8.66% 7.19% 7.35% 7.24%
ROA (Net income/ Total Assets) 2.75% 2.19% 6.49% 14.7% 4.11% 3.59% 3.95% 4.12%
Assets 1 36,106 21,004 48,573 52,270 30,605 53,735 49,553 39,648
Book Value Per Share 2 39.90 39.30 42.40 50.90 50.60 51.30 52.20 53.40
Cash Flow per Share 2 6.290 5.830 6.800 15.00 10.20 8.770 8.620 8.040
Capex 1 1,728 1,423 1,783 2,438 2,671 2,243 2,246 2,269
Capex / Sales 8.97% 7.1% 6.64% 6.59% 9.51% 8.38% 8.18% 8.03%
Announcement Date 20-02-18 21-02-17 22-02-16 23-02-15 24-02-21 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
51.15 USD
Average target price
61.57 USD
Spread / Average Target
+20.37%
Consensus
  1. Stock Market
  2. Equities
  3. NTR Stock
  4. Financials Nutrien Ltd.